RT Journal Article
SR Electronic
A1 Makkar, Raj R.
T1 PARTNER Cohort B: TAVI Superior to Standard Therapy at Two Years
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 14
SP 5
OP 6
DO 10.1177/155989771114003
UL http://mdc.sagepub.com/content/11/14/5.2.abstract
AB Transcatheter aortic valve implantation (TAVI) is the recommended treatment for “inoperable” patients with severe aortic stenosis, based on the 1-year results of the PARTNER trial [NCT00530894; Leon MB et al. N Engl J Med 2010]. The objective of this PARTNER trial analysis was to evaluate the clinical outcomes of TAVI compared with standard therapy at 2 years in patients with inoperable AS [PARTNER Cohort B].